Details for Patent: 11,458,145
✉ Email this page to a colleague
Which drugs does patent 11,458,145 protect, and when does it expire?
Patent 11,458,145 protects ANJESO and is included in one NDA.
This patent has thirteen patent family members in seven countries.
Drugs Protected by US Patent 11,458,145
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baudax | ANJESO | meloxicam | SOLUTION;INTRAVENOUS | 210583-001 | Feb 20, 2020 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | MANAGEMENT OF MODERATE-TO-SEVERE PAIN BY INJECTION | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,458,145
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2019231858 | ⤷ Subscribe | |||
| Australia | 2019364416 | ⤷ Subscribe | |||
| Canada | 3117209 | ⤷ Subscribe | |||
| China | 111201020 | ⤷ Subscribe | |||
| China | 111356453 | ⤷ Subscribe | |||
| European Patent Office | 3761977 | ⤷ Subscribe | |||
| European Patent Office | 3870163 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
